Table 5. Example table: demographic and clinical characteristics of study participants with and without prostate cancer.

	Cases		Controls
Characteristic	N=1308	%	N=1266	%
Age (years)
35–49	102	7.8	107	8.5
50–54	188	14.4	178	14.1
55–59	325	24.9	343	27.1
60–64	395	30.2	334	26.4
65–69	153	11.7	160	12.6
70–74	145	11.1	144	11.4
First degree family history of prostate cancer
No	1025	78.4	1125	88.9
Yes	283	21.6	141	11.1
PSA at diagnosis or interview (ng/ml)
0–3.9	178	13.6	351	27.7
4.0–9.9	721	55.1	33	2.6
10.0–19.9	190	14.5	6	0.5
≥20.0	118	9.0	0	—
Gleason score
2–4	66	5.1
5–6	681	52.2
7=3+4	355	27.2
7=4+3	76	5.8
8–10	126	9.7
Primary treatment
Radical prostatectomy	770	58.9
Radiation	352	26.9
Androgen deprivation therapy	60	4.6
Other treatment	11	0.8
Active surveillance	115	8.8

Adapted from ref. 31.